Evidence map›Paper›PMID 29196611›Full record

ReviewBiochemical Society transactions2018

Cell signaling abnormalities in cardiomyopathy caused by lamin A/C gene mutations.

Howard J Worman

Open access · greenAbstract readReview
In one paragraph

Review in Biochemical Society transactions, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 25 citations in OpenAlex.

  1. Lamin A/C as a biomarker for breast cancer.Molecular biology reports · 2025
    Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Quantification of theInternational journal of molecular sciences · 2019
    Article
  9. Review
  10. Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Howard J WormanDepartment of Medicine, College of Physicians and Surgeons, Columbia University, New York, NY 10032, U.S.A. hjw14@columbia.edu.
Columbia University · US

Funding

Pathogenesis of Emery-Dreifuss Muscular DystrophyR01AR048997 · NIAMS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI WORMAN, HOWARD J · 2003 to 2024
$7.1M
Preclinical Development of Novel MEK1/2 Inhibitors to Treat Inherited CardiomyopaR41TR001008 · NCATS · CHEMINPHARMA, LLC · PI KHIRE, UDAY R · 2013 to 2013
$105k
NCATS NIH HHS R41 TR001008NIAMS NIH HHS R01 AR048997
6 · The paper itself

Abstract

Mutations in the lamin A/C gene (

Indexed as

MutationAnimalsCardiomyopathiesDisease Models, AnimalHumansLamin Type AMechanistic Target of Rapamycin Complex 1MiceMyocardiumProtein KinasesSignal TransductionTransforming Growth Factor betaLamin Type AMechanistic Target of Rapamycin Complex 1Protein KinasesTransforming Growth Factor betacardiomyopathyextracellular signal-regulated kinaseslaminmechanistic target of rapamycinnuclear envelopeprotein kinase B

Identifiers

PMID29196611
PMCPMC6521696
OpenAlexW2773050913

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.